IL1B and neurodegenerative disease: Given the highly documented role of IL-1β in many neuropathological scenarios, our results suggest that specific manipulation of P2X7R pore could be utilized to reduce the degree of microglial activation, and this therapeutic strategy holds promise in the setting of Alzheimer’s and other neurodegenerative diseases, as well as neoplastic conditions where effective interventions are currently lacking.